The big thing with them is they have the #1 Rx
Post# of 405
Posted On: 11/18/2016 7:41:41 AM
The big thing with them is
they have the #1 Rx for sinus.
It will become OTC before too long.
I will decide this morning to buy some now or not.
Website
Net loss totaled $4.4 million, or $0.04 per common share, for the three months ended September 30, 2016. The net loss included interest expense of $3.7 million, of which $3.6 million was non-cash and related to amortization of debt discounts and the excess initial fair value of the embedded conversion feature from our 2016 financing. Net loss for the three months ended September 30, 2015 totaled $0.9 million, or $0.02 per common share.
(0)
(0)Innovus Pharmaceuticals Inc. (INNV) Stock Research Links
Scroll down for more posts ▼